Robert Adams to Clinical Trials as Topic
This is a "connection" page, showing publications Robert Adams has written about Clinical Trials as Topic.
Connection Strength
0.333
-
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.
Score: 0.116
-
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008 May; 39(5):1647-52.
Score: 0.055
-
Trials in sickle cell disease. Pediatr Neurol. 2006 Jun; 34(6):450-8.
Score: 0.049
-
Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. Stroke. 2003 Sep; 34(9):2310-22.
Score: 0.040
-
Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort. Stroke. 2022 11; 53(11):e463-e466.
Score: 0.038
-
Acute stroke treatment trials in the United States. Rethinking strategies for success. Stroke. 1995 Dec; 26(12):2216-8.
Score: 0.024
-
ACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004 Oct 19; 110(16):2506-49.
Score: 0.011